478PClinical evaluation of drug-eluting bead transcatheter arterial chemoembolization(D-TACE) versus conventional TACE in treatment of unresectable hepatocellular carcinoma

ConclusionsIn unresectable HCC, transcatheter treatment with DEB loaded with doxorubicin offers a better objective tumor response than conventional TACE, especially in patients with tumor size less than 7cm and tumor numbers less than 3.Legal entity responsible for the studyThe author.FundingHas not received any funding.DisclosureThe author has declared no conflicts of interest.
Source: Annals of Oncology - Category: Cancer & Oncology Source Type: research